These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5738821)

  • 1. [Toxicity and side effects of cyclophosphamide].
    García Dadoni L; Rafael Seoane M
    Rev Clin Esp; 1968 Apr; 109(1):11-6. PubMed ID: 5738821
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.
    Ershler WB; Hacker MP; Newman RA; Stewart JA; Gamelli RL; Krakoff IH
    Cancer Treat Rep; 1983 Dec; 67(12):1145-7. PubMed ID: 6652633
    [No Abstract]   [Full Text] [Related]  

  • 3. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial with fractionated high doses of cyclophosphamide].
    Macchiavelli M; Leone BA; Romero A; Rabinovich MG; Pérez JE
    Medicina (B Aires); 1986; 46(4):475-6. PubMed ID: 3574114
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of dose-related cyclophosphamide toxicity in patients of head & neck cancers.
    Gadgil SD; Shetty PA; Mehta AR; Nadkarni KS; Jussawalla DJ
    Indian J Cancer; 1980 Mar; 17(1):51-4. PubMed ID: 7399556
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
    Gilheeney SW; Lyden DC; Sgouros S; Antunes N; Gerald W; Kramer K; Lis E; Meyers P; Rosen N; Thaler HT; Trippett T; Wexler L; Dunkel IJ
    Pediatr Blood Cancer; 2007 Sep; 49(3):261-5. PubMed ID: 16972243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclophosphamide and bladder cancer].
    Hem E; Jakobsen A; Urnes T
    Tidsskr Nor Laegeforen; 1984 Jan; 104(1):24-6. PubMed ID: 6695365
    [No Abstract]   [Full Text] [Related]  

  • 8. Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapy.
    de Jonge ME; Huitema AD; Tukker AC; van Dam SM; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2005 Jan; 11(1):273-83. PubMed ID: 15671556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-hematologic adverse effects of cytostatic drugs].
    Singer Z; Kozaczka A; Wilk J; Janas J
    Pol Tyg Lek; 1984 Nov; 39(47):1535-41. PubMed ID: 6240028
    [No Abstract]   [Full Text] [Related]  

  • 10. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
    Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer.
    Recchia F; De Fillipis S; Piccinini M; Rea S
    Anticancer Res; 2003; 23(5b):4141-7. PubMed ID: 14666615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive cyclophosphamide therapy in advanced malignant disease.
    Binns JH; Southall AC
    Practitioner; 1970 Apr; 204(222):546-8. PubMed ID: 5443539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with immunosuppressive agents. Review of literature and personal cases. Results in 45 patients treated with cyclophosphamide for 6 years].
    Frizziero L; Zizzi F; Facchini A; Zini G; Ferruzzi A; Mariani E
    Recenti Prog Med; 1981 Dec; 71(6):612-40. PubMed ID: 7041209
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the question of intestinal absorption disorders in drug therapy of neoplasms].
    Neumeister K; Cilensek M
    Dtsch Gesundheitsw; 1968 Nov; 23(47):2239-40. PubMed ID: 5732684
    [No Abstract]   [Full Text] [Related]  

  • 16. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy (CMF) for breast carcinoma. Patient's compliance and total dose achieved.
    Lee YT
    Am J Clin Oncol; 1983 Feb; 6(1):25-30. PubMed ID: 6687656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
    Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
    Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
    Mardiak J; Sálek T; Sycova-Milá Z; Sufliarsky J; Baláz M; Koza I
    Neoplasma; 2000; 47(4):244-7. PubMed ID: 11043830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
    Linden HM; Haskell CM; Green SJ; Osborne CK; Sledge GW; Shapiro CL; Ingle JN; Lew D; Hutchins LF; Livingston RB; Martino S
    J Clin Oncol; 2007 Feb; 25(6):656-61. PubMed ID: 17308269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.